IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 32 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $9,000 | 0.0% | 79,366 | +109.6% | 0.00% | – |
| Q2 2016 | $9,000 | -18.2% | 37,859 | 0.0% | 0.00% | – |
| Q1 2016 | $11,000 | +57.1% | 37,859 | +97.5% | 0.00% | – |
| Q4 2015 | $7,000 | -12.5% | 19,166 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | 0.0% | 19,166 | +14.3% | 0.00% | – |
| Q2 2015 | $8,000 | 0.0% | 16,773 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | -11.1% | 16,773 | +34.7% | 0.00% | – |
| Q4 2014 | $9,000 | -64.0% | 12,448 | -45.3% | 0.00% | – |
| Q2 2014 | $25,000 | -19.4% | 22,764 | -9.1% | 0.00% | – |
| Q1 2014 | $31,000 | +72.2% | 25,040 | +29.4% | 0.00% | – |
| Q4 2013 | $18,000 | -61.7% | 19,352 | +6.3% | 0.00% | – |
| Q3 2013 | $47,000 | +20.5% | 18,208 | -11.2% | 0.00% | – |
| Q2 2013 | $39,000 | – | 20,514 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,471,500 | $1,199,000 | 0.53% |
| SABBY MANAGEMENT, LLC | 5,889,021 | $2,856,000 | 0.12% |
| Callan Capital, LLC | 323,912 | $157,000 | 0.03% |
| CHELSEA COUNSEL CO | 28,000 | $14,000 | 0.00% |
| Ifrah Financial Services, Inc. | 18,500 | $9,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 366,060 | $178,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 8,000 | $3,000 | 0.00% |
| Gerstein Fisher | 13,000 | $6,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $22,000 | 0.00% |
| NORTHERN TRUST CORP | 99,019 | $48,000 | 0.00% |